Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate

Obstetrics and Gynecology

Volumn 117, Issue 4, 2011, Pages 793-797

  Bonny, Andrea E ^a,b,c,d   Secic, Michelle ^a,b,c   Cromer, Barbara ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b Secic Statistical Consultants   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL CIPIONATE; MEDROXYPROGESTERONE ACETATE;

ADOLESCENT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; COUNSELING; FEMALE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; WEIGHT GAIN;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDROXYPROGESTERONE ACETATE; RISK FACTORS; TIME FACTORS; WEIGHT GAIN;

EID: 79953216741     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31820f387c     Document Type: Article

References (13)

1. Nelson A. Merits of DMPA relative to other reversible contraceptive methods. J Reprod Med 2002;47(9 suppl):781-4.
2. O'Dell CM, Forke CM, Polaneczky MM, Sondheimer SJ, Slap GB. Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents. Obstet Gynecol 1998;91:609-14. (Pubitemid 28153054)
3. Harel Z, Biro FM, Kollar LM, Rauh JL. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. J Adolesc Health 1996;19:118-23. (Pubitemid 26274764)
4. Risser WL, Gefter LR, Barratt MS, Risser JM. Weight change in adolescents who used hormonal contraception. J Adolesc Health 1999;24:433-6. (Pubitemid 29283357)
5. Moore LL, Valuck R, McDougall C, Fink W. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives. Contraception 1995;52:215-9.
6. Templeman C, Boyd H, Hertweck SP. Depomedroxyprogesterone acetate use and weight gain among adolescents. J Pediatr Adolesc Gynecol 2000;13:45-6. (Pubitemid 30488727)
7. Polaneczky M, Liblanc M. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. J Adolesc Health 1998;23:81-8. (Pubitemid 28371283)
8. Bonny AE, Britto MT, Huang B, Succop P, Slap GB. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol 2004;17:109-15. (Pubitemid 38406022)
9. Mangan SA, Larsen PG, Hudson S. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 2002;15:79-82. (Pubitemid 34614922)
10. Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006;160:40-5. (Pubitemid 43042133)
11. Le YC, Rahman M, Berenson AB. Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol 2009;114:279-84.
12. Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 2004;35:434-41. (Pubitemid 39576013)
13. Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril 2008;90:2060-7.